Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (Inmunoferón)

American Journal of Respiratory and Critical Care Medicine

Volumn 163, Issue 7, 2001, Pages 1578-1583

  Prieto, A ^a   Reyes, E ^a   Bernstein, E D ^a   Martinez, B ^a   Monserrat, J ^a   Izquierdo, J L ^a   Callol, L ^a   De Lucas, P ^a   Alvarez Sala, R ^a   Alvarez Sala, J L ^a   Villarrubia, V G ^a   Alvarez Mon, M ^a  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT; INMUNOFERON; PLACEBO;

ADULT; AGED; ARTICLE; CELL ACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY; DOUBLE BLIND PROCEDURE; ESCHERICHIA COLI; FEMALE; HUMAN; IMMUNITY; IN VITRO STUDY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NATURAL KILLER CELL; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL;

EID: 0034948629     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.163.7.2002015     Document Type: Article

References (40)

1. Chronic bronchitis and acute infectious exacerbations
2. 1
3. Predisposing conditions to bacterial infections in chronic obstructive pulmonary disease
4. Prediction of pulmonary immunodeficiency in chronic bronchitis by cutaneous hypoergy to multitest
5. Cutaneous delayed-type hypersensitivity reactions in smokers with chronic bronchitis and recurrent exacerbations: Comparison with asymptomatic smokers and never-smokers
6. Evaluation of systemic host defense mechanisms in chronic bronchitis
7. Immunological findings in blood and bronchoalveolar lavage fluid in chronic bronchitis patients with recurrent infectious exacerbations
8. Local immune components in chronic obstructive pulmonary disease
9. Interleukin 8 in bronchoalveolar lavage of asthmatic and chronic bronchitis patients
10. Immunostimulation of blood monocyte function by RU 41.740 (Biostim) in patients with chronic bronchitis
11. Neutrophil function in chronic bronchitis
12. Inflammatory indices in chronic bronchitis: Monocyte-macrophage microbicidal activity
13. The effects of chronic bronchitis and chronic air-flow obstruction on lung cell populations recovered by bronchoalveolar lavage
14. Leukocyte function and chronic bronchitis
15. Effect of smoking on human natural killer cell activity
16. Immune and inflammatory function in cigarette smokers
17. Airways inflammation in subjects with chronic bronchitis who have never smoked
18. The immunosenescent phenotype in mice and humans can be defined by alterations in the natural immunity reversal by immunomodulation with oral AM3
19. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
20. Host defense against infection
21. Disorders of phagocytic cells
22. The role of infection in COPD
23. Efficacy and safety of a new biological response modifier (AM3) in the prevention of recurrent acute infections in chronic obstructive bronchitis (COB)
24. Therapeutic impact of AM3 (biological response modifier) on prevention of recurrent acute infections of the respiratory tract: Analysis of 683 persons at high risk
25. Las infecciones agudas recidivantes en la EPOC en el medio laboral y prevención con Inmunoferón
26. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease
27. AM3 restores NK and macrophage antitumor cytotoxic activities in immunocompromised mice
28. Hepatitis B virus and the inflammatory/immunologic response (II): A new opportunity for the treatment of chronic hepatitis B and a suggestion for the treatment of other persistent viral diseases
29. Inmunoferón (AM3) enhances the activities of early-type interferon inducers and natural killer cells
30. Therapeutic response of chronic active hepatitis B (CAHB) to a new immunomodulator: AM3. Immunohematological effects
31. AM3, an adjuvant to hepatitis B revaccination in non-responder healthy persons
32. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
33. Severe chronic autoimmune thrombocytopenic purpura is associated with an expansion of CD56+ CD3- natural killer cells subset
34. A low blood lymphocyte count is associated with an expansion of activated cytotoxic T lymphocytes in patients with B cell chronic lymphocytic leukemia
35. Phagotest and Bursttest (Phagoburst), test kits for study of phagocyte functions
36. Effect of smoking on natural killer cell activity in the lung
37. Seasonal variation in the function of blood monocytes obtained from healthy nonsmokers, asymptomatic smokers, and smokers with chronic bronchitis
38. Non specific immunity in aged healthy subjects and in patients with chronic bronchitis
39. Quantitative flow cytometric analysis of opsonophagocytosis and killing of nonencapsulated Haemophilus influenzae by human polymorphonuclear leukocytes
40. Simultaneous respiratory tract colonization by multiple strains of non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease: Implications for antibiotic therapy